Clinical utility of genomic signatures in young breast cancer patients: a systematic review.

NPJ Breast Cancer · 2020 · PMC7519162 · PMID 33062888

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

First, it is worth noting that in both the TAILORx and MINDACT trials, subgroup analysis according to age were not preplanned and, in some cases, did not reach statistical significance, making it hard to justify challenging the clinical utility of these genomic tests in younger women based solely on these analyses.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.